Programmed cell death is impaired in the developing brain of fmr1 mutants

Developmental Neuroscience

Volumn 35, Issue 4, 2013, Pages 347-358

  Cheng, Ying ^a   Corbin, Joshua G ^b   Levy, Richard J ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Autism; Brain; Development; Fragile X syndrome; Programmed cell death

Indexed keywords

CASPASE 3; CYTOCHROME C; CYTOCHROME C PEROXIDASE; FRAGILE X MENTAL RETARDATION PROTEIN; PROCASPASE 9; PROTEIN BAX; PROTEIN BCL XL;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BASOLATERAL AMYGDALA; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN MITOCHONDRION; BRAIN REGION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOREBRAIN; FRAGILE X SYNDROME; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEOCORTEX; NERVE CELL; NEWBORN; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPTOGENESIS;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-ASSOCIATED DEATH PROTEIN; BLOTTING, WESTERN; BRAIN; CASPASE 3; CELL COUNT; CYTOCHROME-C PEROXIDASE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HEME; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; NEURONS; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION;

EID: 84883458323     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000353248     Document Type: Article

References (40)

1. Olmos-Serrano JL, Paluszkiewicz SM, Martin BS, et al: Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J Neurosci 2010; 30: 9929-9938.
2. Budimirovic DB, Kaufmann WE: What Can We Learn about Autism from Studying Fragile X Syndrome? Dev Neurosci 2011; 33: 379-394.
3. Olmos-Serrano JL, Corbin JG, Burns MP: The GABA A Receptor Agonist THIP Ameliorates Specific Behavioral Deficits in the Mouse Model of Fragile X Syndrome. Dev Neurosci 2011; 33: 395-403.
4. Brodkin ES: Social behavior phenotypes in fragile X syndrome, autism, and the Fmr1 knockout mouse: Theoretical comment on McNaughton et al. Behav Neurosci 2008; 122: 483-489.
5. Amaral DG, Schumann CM, Nordahl CW: Neuroanatomy of autism. Trends Neurosci 2008; 31: 137-145.
6. Courchesne E, Campbell K, Solso S: Brain growth across the life span in autism: Age-specific changes in anatomical pathology. Brain Res 2011; 1380: 138-145.
7. Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, Barnes CC, Pierce K: Neuron number and size in prefrontal cortex of children with autism. JAMA 2011; 306: 2001-2010.
8. Gatto CL, Broadie K. Fragile X mental retardation protein is required for programmed cell death and clearance of developmentallytransient peptidergic neurons. Dev Biol 2011; 356: 291-307 .
9. Callan MA, Cabernard C, Heck J, Luois S, Doe CQ, Zarnescu DC: Fragile X protein controls neural stem cell proliferation in the Drosophila brain. Hum Mol Genet 2010; 19: 3068-3079.
10. Chan WY, Lorke DE, Tiu SC, Yew DT: Proliferation and apoptosis in the developing human neocortex. Anat Rec 2002; 267: 261-276.
11. Rice D, Barone S Jr.: Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models. Environ Health Perspect. 2000; 108: 511-533.
12. Sanno H, Shen X, Kuru N, Bormuth I, Bobsin K, Gardner HA, Komljenovic D, Tarabykin V, Erzurumlu RS, Tucker KL: Control of postnatal apoptosis in the neocortex by RhoAsubfamily GTPases determines neuronal density. J Neurosci 2010; 30: 4221-4231.
13. Clancy B, Finlay BL, Darlington RB, Anand KJ: Extrapolating brain development from experimental species to humans. Neurotoxicology 2007; 28: 931-937.
14. Hornig M, Chian D, Lipkin WI: Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 2004; 9: 833-845.
15. Klintsova AY, Helfer JL, Calizo LH, Dong WK, Goodlett CR, Greenough WT: Persistent impairment of hippocampal neurogenesis in young adult rats following early postnatal alcohol exposure. Alcohol Clin Exp Res 2007; 31: 2073-2082.
16. Stenqvist A, Agerman K, Marmigère F, Minichiello L, Ernfors P: Genetic evidence for selective neurotrophin 3 signalling through TrkC but not TrkB in vivo. EMBO Rep 2005; 6: 973-978.
17. Kwon MS, et al: Neuroprotective Effect of Visnagin on Kainic Acid-induced Neuronal Cell Death in the Mice Hippocampus. Korean J Physiol Pharmacol 2010; 14: 257-263.
18. Franklin KBJ, Paxinos G: The mouse brain in stereotaxic coordinates; San Diego: Academic Press, 1997.
19. Paxinos G, Watson C: Atlas of the developing mouse brain: At E17.5, PO, and P6; San Diego: Academic Press, 2007.
20. Jacobs EE, Sanadi DR: The reversible removal of cytochrome c from mitochondria. J Biol Che 1960; 235: 531-534.
21. Kim NH, Jeong MS, Choi SY, Kang JH: Peroxidase Activity of Cytochrome c. Bull. Korean Chem. Soc 2004; 25: 1889-1892.
22. Cheng Y, Thomas A, Mardini F, Bianchi SL, Tang JX, Peng J, Wei H, Eckenhoff MF, Eckenhoff RG, Levy RJ: Neurodevelopmental consequences of sub-clinical carbon monoxide exposure in newborn mice. PLoS One 2012; 7:e32029.
23. Ozawa T, Tanaka, M, Shimomura, Y: Crystallization of the middle part of the mitochondrial electron transfer chain: Cytochrome bc1-cytochrome c complex. Proc Natl Acad Sci USA 1980; 77: 5084-5086.
24. Tanaka M, Ogawa, N., Ihara, K., Sugiyama, Y., Mukohata, Y: Cytochrome aa(3) in Haloferax volcanii. J Bacteriol 2002; 184: 840-845.
25. Ferrer I, Bernet E, Soriano E, del Rio T, Fonseca M: Naturally occurring cell death in the cerebral cortex of the rat and removal of dead cells by transitory phagocytes. Neuroscience 1990; 39: 451-458.
26. Ferrer I, Serrano T, Soriano E: Naturally occurring cell death in the subicular complex and hippocampus in the rat during development. Neurosci Res 1990; 8: 60-66.
27. Kim WR, Sun W: Programmed cell death during postnatal development of the rodent nervous system. Dev Growth Differ 2011; 53: 225-235.
28. Bureau I, Shepherd GM, Svoboda K: Circuit and plasticity defects in the developing somatosensory cortex of FMR1 knock-out mice. J Neurosci 2008; 28: 5178-5188.
29. Vanderhaeghen P, Cheng HJ: Guidance molecules in axon pruning and cell death. Cold Spring Harb Perspect Biol 2010; 2:a001859.
30. Precht TA, Phelps RA, Linseman DA, Butts BD, Le SS, Laessig TA, Bouchard RJ, Heidenreich KA: The permeability transition pore triggers Bax translocation to mitochondria during neuronal apoptosis. Cell Death Differ 2005; 12: 255-265.
31. Singh BK, Tripathi M, Chaudhari BP, Pandey PK, Kakkar P: Natural terpenes prevent mitochondrial dysfunction, oxidative stress and release of apoptotic proteins during nimesulide-hepatotoxicity in rats. PLoS One 2012; 7:e34200.
32. Llambi F, Moldoveanu T, Tait SW, Bouchier-Hayes L, Temirov J, McCormick LL, Dillon CP, Green DR: A unified model of mammalian BCL-2 protein family interactions at the mitochondria. Mol Cell 2011; 44: 517-531.
33. Renault TT, Teijido O, Antonsson B, Dejean LM, Manon S: Regulation of Bax mitochondrial localization by Bcl-2 and Bcl-x(L): Keep your friends close but your enemies closer. Int J Biochem Cell Biol 2013; 45: 64-67.
34. Sen P, Mukherjee S, Ray D, Raha S: Involvement of the Akt/PKB signaling pathway with disease processes. Mol Cell Biochem 2003; 253: 241-246.
35. Sharma A, Hoeffer CA, Takayasu Y, Miyawaki T, McBride SM, Klann E, Zukin RS: Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 2010; 30: 694-702.
36. Comery TA, Harris JB, Willems PJ, Oostra BA, et al: Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits. Proc Natl Acad Sci U.S.A. 1997; 94: 5401-5404.
37. Zang JB, Nosyreva ED, Spencer CM, et al: A mouse model of the human Fragile X syndrome I304N mutation. PLoS Genet 2009; 5:e1000758.
38. He L, Perkins GA, Poblenz AT, Harris JB, Hung M, Ellisman MH, Fox DA: Bcl-xL overexpression blocks bax-mediated mitochondrial contact site formation and apoptosis in rod photoreceptors of lead-exposed mice. Proc Natl Acad Sci U.S.A. 2003; 100: 1022-1027.
39. Lüscher C, Huber KM: Group 1 mGluR-dependent synaptic long-term depression: Mechanisms and implications for circuitry and disease. Neuron 2010; 65: 445-459.
40. Bekay R, Romero-Zerbo Y, Decara J, Sanchez-Salido L, Del Arco-Herrera I, Rodríguez-de Fonseca F, de Diego-Otero Y: Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome. Eur J Neurosci 2007; 26: 3169-3180.